Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Encompass Health CorpEHC · Entity 3460 | Director | April 18, 2022 | April 20, 2022 |
| Enhabit, Inc.EHAB · Entity 46765 | Director | June 28, 2023 | June 30, 2023 |
| MSA Safety IncMSA · Entity 3692 | Director | May 13, 2019 | May 14, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Encompass Health Corp
Report date April 18, 2022 · Filed April 20, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Encompass Health Common StockSEC Table I · non-derivative | Direct | 99,385 |
Ending reported balance
After 2022-04-19 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-04-18 · Grant · Acquired 298 · Balance 99,325 F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Row 2 · 2022-04-19 · Grant · Acquired 60 · Balance 99,385 F2: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 18, 2022, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.
F2: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 18, 2022, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.
Enhabit, Inc.
Report date June 28, 2023 · Filed June 30, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,691 |
Reported balance
After 2023-06-28 transaction · row 1
1 source rowRow 1 · 2023-06-28 · Grant · Acquired 12,702 · Balance 51,691 |
MSA Safety Inc
Report date May 13, 2019 · Filed May 14, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, no par valueSEC Table I · non-derivative | Direct | 442,238 |
Ending reported balance
After 2019-05-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-05-13 · Exercise / conversion · Acquired 4,854 · Balance 447,092 Row 2 · 2019-05-13 · Sale · Disposed 4,854 · Balance 442,238 |
| Non-statutory Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $21.71 · Expires 2019-05-15 | Direct | 0 |
Reported balance
After 2019-05-13 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-05-13 · Exercise / conversion · Disposed 4,854 · Balance 0 |
| Common Stock, no par valueSEC Table I · non-derivative | IndirectBy Wife | 79,123 |
Reported balance
Holding disclosure · report date 2019-05-13 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 79,123 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2016 Filed Jan 23, 2018 17:29 UTC | MSA Safety Inc MSA · Entity 3692 | SaleCommon Stock, no par value | 7,821 | $61.67 | $482,297.61 |
DisclosureSEC source: 0001225208-18-001366 · doc5.xml · nonDerivative · entry 2 SHAW L EDWARD JR · CIK 0001183337 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife as Trustee Disclosed balance after: 140,000 F1 · balance_after: The reporting person's spouse is the trustee of the Rory Shaw Trust, of which his son is the beneficiary. The reported sale is from such trust. Read SEC document |
| November 15, 2016 Filed Jan 23, 2018 17:29 UTC | MSA Safety Inc MSA · Entity 3692 | SaleCommon Stock, no par value | 5,000 | $61.94 | $309,690.00 |
DisclosureSEC source: 0001225208-18-001366 · doc5.xml · nonDerivative · entry 1 SHAW L EDWARD JR · CIK 0001183337 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife as Trustee Disclosed balance after: 147,821 F1 · balance_after: The reporting person's spouse is the trustee of the Rory Shaw Trust, of which his son is the beneficiary. The reported sale is from such trust. Read SEC document |
| October 18, 2016 Filed Oct 19, 2016 18:01 UTC | Encompass Health Corp HLS · Entity 3460 | GrantHealthsouth Common Stock | 83 | $40.35 | $3,348.97 |
DisclosureSEC source: 0001127602-16-065007 · form4.xml · nonDerivative · entry 2 SHAW L EDWARD JR · CIK 0001183337 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,805 F2 · shares: Pursuant to HealthSouth Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of HealthSouth common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of HealthSouth common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On October 17, 2016, the Company paid a dividend on common stock of $0.24 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of HealthSouth in the market with that dividend payment. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 18:01 UTC | Encompass Health Corp HLS · Entity 3460 | GrantHealthsouth Common Stock | 346 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-065007 · form4.xml · nonDerivative · entry 1 SHAW L EDWARD JR · CIK 0001183337 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,722 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 17, 2016, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.